Literature DB >> 1309890

Divergent envelope E2 alphavirus sequences spanning amino acids 297 to 352 induce in mice virus-specific protective immunity and antibodies with complement-mediated cytolytic activity.

H Grosfeld1, S Lustig, Y Gozes, B Velan, S Cohen, M Leitner, B Lachmi, D Katz, U Olshevski, A Shafferman.   

Abstract

We have proposed a general algorithm for identification of potential immunoprotective domains (cassettes) on the envelope E2 polypeptide of alphaviruses (H. Grosfeld, B. Velan, M. Leitner, S. Cohen, S. Lustig, B.E. Lachmi, and A. Shafferman, J. Virol. 63:3416-3422, 1989). To assess the generality of our approach, we compared analogous E2 cassettes from Sindbis virus (SIN) and Semliki Forest virus (SFV), two alphaviruses which are philogenetically very remote. The antigenically distinct SFV E2 and SIN E2 cassettes exhibit comparable immunological characteristics. Most significantly, the SIN E2 LMN cassette cluster (E2 amino acids 297 to 352 fused to beta-galactosidase), like the analogous SFV E2 LMN cassettes, elicited high titers of antivirus antibodies in mice and proved to be highly effective in protection against lethal challenge. Mice immunized with SIN E2 LMN were completely protected against intracerebral challenge of 10 to 100 50% lethal doses of different neurovirulent SIN strains. Anti-SIN LMN antibodies, like anti-SFV LMN antibodies, lacked in vitro neutralizing activity, yet both exerted protection against homologous challenge upon transfer to mice. The two antibody preparations exhibited virus-specific complement-mediated cytolysis of cells infected with the homologous but not heterologous virus. These results suggest a possible mechanism for virus-specific E2 LMN-induced protection and demonstrate the generality of our methodology for deciphering immunogenic and protective domains in alphavirus systems. Results suggest also that the E2 LMN sequence of any given alphavirus should be considered as a component of a synthetic vaccine against that specific virus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309890      PMCID: PMC240812     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Antibody-selected variation and reversion in Sindbis virus neutralization epitopes.

Authors:  D S Stec; A Waddell; C S Schmaljohn; G A Cole; A L Schmaljohn
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

Review 2.  Peptides as immunogens: prospects for synthetic vaccines.

Authors:  R Arnon
Journal:  Curr Top Microbiol Immunol       Date:  1986       Impact factor: 4.291

Review 3.  Molecular pathogenesis of Sindbis virus encephalitis in experimental animals.

Authors:  D E Griffin
Journal:  Adv Virus Res       Date:  1989       Impact factor: 9.937

4.  Alternative forms of a strain-specific neutralizing antigenic site on the Sindbis virus E2 glycoprotein.

Authors:  N L Davis; D F Pence; W J Meyer; A L Schmaljohn; R E Johnston
Journal:  Virology       Date:  1987-11       Impact factor: 3.616

5.  An evolutionary tree relating eight alphaviruses, based on amino-terminal sequences of their glycoproteins.

Authors:  J R Bell; R M Kinney; D W Trent; E G Strauss; J H Strauss
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

6.  Antigenic characterization of two sindbis envelope glycoproteins separated by isoelectric focusing.

Authors:  J M Dalrymple; S Schlesinger; P K Russell
Journal:  Virology       Date:  1976-01       Impact factor: 3.616

7.  Characterization of Sindbis virus epitopes important for penetration in cell culture and pathogenesis in animals.

Authors:  R A Olmsted; W J Meyer; R E Johnston
Journal:  Virology       Date:  1986-01-30       Impact factor: 3.616

8.  Nucleotide sequence of the genome region encoding the 26S mRNA of eastern equine encephalomyelitis virus and the deduced amino acid sequence of the viral structural proteins.

Authors:  G J Chang; D W Trent
Journal:  J Gen Virol       Date:  1987-08       Impact factor: 3.891

9.  Western equine encephalitis virus is a recombinant virus.

Authors:  C S Hahn; S Lustig; E G Strauss; J H Strauss
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

10.  Molecular determinants of alphavirus neurovirulence: nucleotide and deduced protein sequence changes during attenuation of Venezuelan equine encephalitis virus.

Authors:  B J Johnson; R M Kinney; C L Kost; D W Trent
Journal:  J Gen Virol       Date:  1986-09       Impact factor: 3.891

View more
  1 in total

1.  Suppressors of cleavage-site mutations in the p62 envelope protein of Semliki Forest virus reveal dynamics in spike structure and function.

Authors:  I Tubulekas; P Liljeström
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.